Key result
Pulmonary rehabilitation with at least 4 weeks of exercise reduced CRP levels compared to usual care in patients with COPD (MD -1.19; 95% CI -1.78 to -0.60), but did not significantly affect IL-6.
Why the study?
Chronic obstructive pulmonary disease is associated with elevated proinflammatory biomarkers, but the impact of pulmonary rehabilitation on systemic inflammation is unknown.
Does pulmonary rehabilitation reduce inflammatory biomarkers (IL-6, fibrinogen, CRP) in patients with COPD?
Meta-Analysis (n=1,339)
Does pulmonary rehabilitation reduce inflammatory biomarkers (IL-6, fibrinogen, CRP) in patients with COPD?
Mean Difference: -1.19 (95% CI -1.78–-0.6)
Pulmonary rehabilitation of at least 4 weeks may reduce CRP levels in COPD patients, though evidence is of low quality and other biomarkers like IL-6 are unaffected.
PR may lower CRP in COPD without affecting IL-6; leaves anti-inflammatory role and practice change open pending higher-quality data.
INTRODUCTION Chronic obstructive pulmonary disease (COPD) is associated with elevated levels of proinflammatory biomarkers which may contribute to pathophysiological changes in both the respiratory and extrapulmonary systems. Pulmonary rehabilitation (PR) is an effective intervention for symptom management in people with COPD. The impact of PR on systemic inflammation is currently unknown.MATERIALS AND METHODS Using the search terms “chronic obstructive pulmonary disease,” “pulmonary rehabilitation” and “inflammatory biomarkers,” 5 databases were searched from inception. Studies were eligible if they included: (1) participants with COPD undergoing PR with an exercise component of at least 4 weeks in length and (2) a systemic inflammation measurement pre- and post-PR. Our primary outcomes of interest were interleukin-6 (IL-6), fibrinogen and c-reactive protein (CRP) concentrations. A meta-analysis was performed using weighted mean difference and 95% confidence intervals.RESULTS A total of 1339 participants were enrolled across all 18 eligible studies. A meta-analysis of the 5 randomized controlled trials (RCTs) found that CRP (MD −1.19, 95% CI −1.78 to −0.60, I2 = 86%) showed a greater response to PR than usual care. No difference between groups was noted for IL-6 (MD −3.38, 95% CI −13.03 to 6.28, I2 = 98%). Fibrinogen was not reported among included RCTs.CONCLUSION A PR program with at least 4 weeks of exercise appears to reduce CRP levels but not IL-6 or fibrinogen in people with COPD. These results are based on small sample sizes and low-quality evidence and the impact of PR on systemic inflammation is uncertain.
No takes yet. Share an insight, caveat, or question.
Farley et al. (2025) conducted a meta-analysis in chronic obstructive pulmonary disease (n=1,339). Pulmonary rehabilitation vs. Usual care was evaluated on C-reactive protein (CRP) concentrations (MD -1.19, 95% CI -1.78 to -0.60). Pulmonary rehabilitation with at least 4 weeks of exercise reduced CRP levels compared to usual care in patients with COPD (MD -1.19; 95% CI -1.78 to -0.60), but did not significantly affect IL-6.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: